01.22.26 -- The Next Stage Of Clinical Trial Transformation

In this segment, Lois Kelly, VP of Research and Clinical Operations at the National Down Syndrome Society, describes how shared holidays, team events, and open communication helped FSP staff feel valued.

Targeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.

Explore how SGS's Hudson facility can enhance your drug development process by providing cutting-edge bioanalytical testing solutions and seamless global support.

It is crucial to ensure that CGT supply chain risks are mitigated and that proactive strategies are implemented to address unforeseen challenges before they become an issue.

Explore how a platform integrating drug substance, drug product, and clinical testing within a single organization accelerates development and reduces costs, helping deliver positive outcomes earlier.

Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.

Move drug development into the modern era with a CRO that offers assay development and validation, bioanalytical testing, sample prep, and more.

Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.

Achieving global regulatory approvals through deep scientific expertise and extensive knowledge across a range of specialized therapeutic indications.

Engage early with regulatory and clinical experts to navigate evolving global requirements and ensure your first-in-human strategy supports downstream development and multinational approvals.

This 2024 Industry Pages report provides an in-depth examination of the Central and Eastern European (CEE) clinical trial strategy, highlighting its pivotal role in global drug development.

Take an in-depth look and the challenges and benefits of incorporating AI solutions to enhance Medical Information (MI) services and the necessity of regulatory compliance.

Get your clinical trial to the start line while ensuring participant health and safety. Learn how we are uniquely positioned to meet your cost and speed requirements.